Two Sigma Investments
VOR icon

Two Sigma Investments’s Vor Biopharma VOR Stock Holding History

Two Sigma Investments’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,482
Closed -$275K – 3951
2025
Q2 		$275K Buy
8,482
+2,332
+38% +$20.6K ﹤0.01% 2822
2025
Q1 		$88.2K Sell
6,150
-2,003
-25% -$48.1K ﹤0.01% 2979
2024
Q4 		$181K Buy
8,153
+1,296
+19% +$21.5K ﹤0.01% 2890
2024
Q3 		$96K Buy
+6,857
New +$125K ﹤0.01% 2904
2023
Q3 		– Sell
-1,405
Closed -$86.8K – 3238
2023
Q2 		$86.8K Buy
1,405
+349
+33% +$31.9K ﹤0.01% 2771
2023
Q1 		$114K Sell
1,056
-1,664
-61% -$184K ﹤0.01% 2656
2022
Q4 		$362K Buy
2,720
+1,990
+273% +$197K ﹤0.01% 2168
2022
Q3 		$58K Buy
+730
New +$71.8K ﹤0.01% 2302

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments's VOR Position: Q3 2025 in Review

Two Sigma Investments sold out of Vor Biopharma (VOR) in Q3 2025, closing a stake of 8,482 shares — an estimated $275K sold.

Two Sigma Investments first reported a position in VOR in Q3 2022 and held it in 8 quarters. The position peaked at $362K in Q4 2022. 37 funds tracked by Wall St. Rank hold VOR as of Q3 2025.

  • Two Sigma Investments reported no remaining Vor Biopharma position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 8,482 Vor Biopharma shares in Q3 2025, an estimated $275K.
  • Two Sigma Investments first reported a position in Vor Biopharma in Q3 2022 and held it in 8 quarters.
  • Two Sigma Investments's Vor Biopharma position peaked at $362K in Q4 2022.
  • 37 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.